340B hospitals are under significant pressure due to drug manufacturers ending 340B discounts on drugs dispensed by contract pharmacies, hospital advocacy group 340B Health says in its latest annual member survey.
Nearly 500 hospitals that are members of 340B Health, a trade group representing 340B hospitals, responded to the survey. It found that critical access hospitals (CAHs)—facilities with 25 or fewer beds typically located in highly isolated locations—derive 51 percent of their 340B savings through contract pharmacies, while disproportionate share (DSH) hospitals reported receiving 26 percent of their savings through contract pharmacy arrangements.
340B hospitals are under significant pressure due to drug manufacturers ending 340B discounts on drugs dispensed by contract pharmacies, hospital advocacy group 340B Health says in its latest annual member survey.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
